ReviewPublic health challenges2023
The state of human papillomavirus research in Africa.
Review in Public health challenges, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Financing of Human Papillomavirus Vaccination in Africa: A Scoping Review.Health science reports · 2026Review
- Global health trends of human papillomavirus-associated oral cancer: A review.Public health challenges · 2023Review
- The state of global research on poverty after SDG declaration.Public health challenges · 2023Review
- The state of human papillomavirus research in Africa.Public health challenges · 2023Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Human papillomavirus (HPV) research scholarship evaluation is pivotal to the strategic planning, implementation and sustainability of HPV prevention and control programmes in Africa. Hence, this study evaluated HPV research scholarship in Africa. Methods: This review-a bibliometric analysis-investigated the trends, patterns, dynamics and funding of HPV-related literature production in Africa with a focus on the inequalities existing across thematic and subject areas, researchers, institutions and countries/territories/dependencies. The study data were obtained from SCOPUS database and analysed using the Microsoft Excel 2021 software. Result: From 1974 (inception year) till 16 July 2022, a total of 2587 SCOPUS-indexed literature on HPV were produced by African authors, with an average production rate of 50.5 publications per year (1974-2021). A few publications (1.2%) were in the Social Sciences. Most (95.1%) publications were in English, only a few (3.9%) were in French, whereas none was in Arabic, Portuguese, Spanish, Swahili or any other official language of the African Union. South Africa, Nigeria and Egypt were the three most prolific African countries. The 10 most prolific researchers were affiliated to public institutions in South Africa, Tanzania and Botswana. The top 10 funding sponsors were public institutions in the United States, the United Kingdom, Belgium and South Africa. Moreover, researchers and institutions affiliated to South Africa, Nigeria, Kenya and Uganda were the predominant beneficiaries. Only two indigenous journals made the list of top 10 journals publishing HPV research outputs from Africa. Conclusion: Scholarly HPV research productivity in Africa is very low and worsened by multiple inequality gaps. There is an urgent need for equitably strengthening HPV research capacity in Africa.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.